The botanical extracts of Achyrocline satureoides and Ilex paraguariensis prevent methylglyoxal-induced inhibition of plasminogen and antithrombin III

被引:56
作者
Gugliucci, A [1 ]
Menini, T [1 ]
机构
[1] Touro Univ, Coll Osteopath Med, Biochem Lab, Div Basic Med Sci, Vallejo, CA 94592 USA
关键词
antioxidant; flavonoids; methylglyoxal; phytochemicals; glycation; aminoguanidine; carnosine; diabetes; carbonyl stress;
D O I
10.1016/S0024-3205(02)02242-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Endogenously produced dicarbonyls, such as methylglyoxal (MG), are involved in advanced glycation end-product formation and thus linked to the pathophysiology of diabetic chronic complications. While the search for synthetic new antiglycation agents continues, little attention has been paid to putative antiglycation agents in natural compounds. Given the link between glycation and oxidation, in this work, we study the effects of methylglyoxal on two model systems; plasminogen and antithrombin III (AT III), then we set out to unravel a possible antiglycation effect for extracts of the flavonoid-rich common herbal species Achyrocline satureoides (AS) and Ilex paraguariensis JP). Using SAR-PRO-ARG-pNA as a specific thrombin substrate, we show that incubation of plasma with MG decreases heparin activation of AT III by up to a 70%, in a dose-dependent manner. A parallel dose-dependent decrease in plasminogen activity reaching more than 50% was shown using D-BUT-CHT-lys-pNA as a plasmin-specific substrate. Extracts of AS and IP display a dose dependent inhibition of the action of the dicarbonyl, already significant at a 1/100 dilution of the herbal infusions. The inhibition was comparable to that obtained by using millimolar concentrations of known AGE inhibitors such as aminoguanidine and carnosine as well as micromolar concentrations of the antioxidant ascorbic acid. We believe our system of whole plasma glycation over 16 h with micromolar concentrations of MG, coupled with the measurement of activities of plasminogen and AT III by specific substrates provides a straightforward, practical method for monitoring the action of putative antiglycation agents. If predictably milder glycated forms of AT III and plasminogen were to be secreted in vivo, the loss of activities shown here could act synergistically to generate hyperthrombicity. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:279 / 292
页数:14
相关论文
共 47 条
[1]   N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins [J].
Ahmed, MU ;
Frye, EB ;
Degenhardt, TP ;
Thorpe, SR ;
Baynes, JW .
BIOCHEMICAL JOURNAL, 1997, 324 :565-570
[2]   Adaptive response of human melanoma cells to methylglyoxal injury [J].
Amicarelli, F ;
Bucciarelli, T ;
Poma, A ;
Aimola, P ;
Di Ilio, C ;
Ragnelli, AM ;
Miranda, M .
CARCINOGENESIS, 1998, 19 (03) :519-523
[3]   Morphofunctional mitochondrial response to methylglyoxal toxicity in Bufo bufo embryos [J].
Amicarelli, F ;
Colafarina, S ;
Cesare, P ;
Aimola, P ;
Di Ilio, C ;
Miranda, M ;
Ragnelli, AM .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (11) :1129-1139
[4]   Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients [J].
Andersen, T ;
Fogh, J .
JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2001, 14 (03) :243-250
[5]   Glycoxidation and lipoxidation in atherogenesis [J].
Baynes, JW ;
Thorpe, SR .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) :1708-1716
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Negative consequences of glycation [J].
Brownlee, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (02) :9-13
[8]   Achyrofuran, a new antihyperglycemic dibenzofuran from the South American medicinal plant Achyrocline satureioides [J].
Carney, JR ;
Krenisky, JM ;
Williamson, RT ;
Luo, J .
JOURNAL OF NATURAL PRODUCTS, 2002, 65 (02) :203-205
[9]   Diabetes mellitus - A hypercoagulable state [J].
Carr, ME .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2001, 15 (01) :44-54
[10]  
CERIELLO A, 1987, DIABETES METAB, V13, P16